116 related articles for article (PubMed ID: 17620983)
1. Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of Parkinson disease.
Cepeda IL; Flores J; Cornfeldt ML; O'Kusky JR; Doudet DJ
J Neuropathol Exp Neurol; 2007 Jul; 66(7):576-84. PubMed ID: 17620983
[TBL] [Abstract][Full Text] [Related]
2. Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease.
Flores J; Cepeda IL; Cornfeldt ML; O'Kusky JR; Doudet DJ
J Neuropathol Exp Neurol; 2007 Jul; 66(7):585-96. PubMed ID: 17620984
[TBL] [Abstract][Full Text] [Related]
3. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response.
Subramanian T; Marchionini D; Potter EM; Cornfeldt ML
Cell Transplant; 2002; 11(3):207-14. PubMed ID: 12075986
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Pinna A; Pontis S; Borsini F; Morelli M
Synapse; 2007 Aug; 61(8):606-14. PubMed ID: 17476684
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model.
Goren B; Kahveci N; Eyigor O; Alkan T; Korfali E; Ozluk K
Surg Neurol; 2005; 64 Suppl 2():S33-41. PubMed ID: 16256839
[TBL] [Abstract][Full Text] [Related]
6. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease.
Watts RL; Raiser CD; Stover NP; Cornfeldt ML; Schweikert AW; Allen RC; Subramanian T; Doudet D; Honey CR; Bakay RA
J Neural Transm Suppl; 2003; (65):215-27. PubMed ID: 12946059
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
8. Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism.
Senthilkumar KS; Saravanan KS; Chandra G; Sindhu KM; Jayakrishnan A; Mohanakumar KP
Behav Brain Res; 2007 Nov; 184(1):11-8. PubMed ID: 17765334
[TBL] [Abstract][Full Text] [Related]
9. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.
Stover NP; Bakay RA; Subramanian T; Raiser CD; Cornfeldt ML; Schweikert AW; Allen RC; Watts RL
Arch Neurol; 2005 Dec; 62(12):1833-7. PubMed ID: 16344341
[TBL] [Abstract][Full Text] [Related]
10. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
Willis GL; Kelly AM; Kennedy GA
Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
Falk T; Zhang S; Sherman SJ
Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875
[TBL] [Abstract][Full Text] [Related]
12. Neonatal human retinal pigment epithelial cells secrete limited trophic factors in vitro and in vivo following striatal implantation in parkinsonian rats.
Russ K; Flores J; Brudek T; Doudet D
J Neural Transm (Vienna); 2016 Mar; 123(3):167-77. PubMed ID: 26546037
[TBL] [Abstract][Full Text] [Related]
13. Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats.
Russ K; Flores J; Brudek T; Doudet DJ
J Neural Transm (Vienna); 2017 Apr; 124(4):455-462. PubMed ID: 28160153
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
Lane EL; Soulet D; Vercammen L; Cenci MA; Brundin P
Neurobiol Dis; 2008 Nov; 32(2):220-8. PubMed ID: 18675359
[TBL] [Abstract][Full Text] [Related]
15. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation.
Peng S; Ma Y; Flores J; Cornfeldt M; Mitrovic B; Eidelberg D; Doudet DJ
J Nucl Med; 2016 Oct; 57(10):1591-1598. PubMed ID: 27056614
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
18. Retinal pigment epithelial cells: biological property and application in Parkinson's disease.
Ming M; LE WD
Chin Med J (Engl); 2007 Mar; 120(5):416-20. PubMed ID: 17376314
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of computer-assisted stereotactic transplantation of human retinal pigment epithelium cells in the treatment of Parkinson disease.
Xue Y; Li X; Pang S; Wang Y; Yao J; Zhou J; Hao P
J Comput Assist Tomogr; 2013; 37(3):333-7. PubMed ID: 23674001
[TBL] [Abstract][Full Text] [Related]
20. [Cell transplantation study with German patients. Can retinal cells save the Parkinson brain?].
Sturm V
MMW Fortschr Med; 2004 Jan; 146(1-2):9. PubMed ID: 18441571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
